What are peptides? Peptides are short chains of amino acids linked together by chemical bonds called peptide bonds. They are made naturally by every living thing, from bacteria to plants to people, and many of them act as messengers, regulators, or defenders. Scientists can also make peptides in the laboratory, which is why they show up in medicine, research, and laboratory testing.
This guide explains what peptides are, how they are built, what they do, and why their quality is measured so carefully. No chemistry background is needed.
Key Takeaways
- A peptide is a chain of amino acids joined by peptide bonds (a type of amide bond) [1].
- There is no single official size cut-off between a "peptide" and a "protein". Scientists and regulators draw the line in different places [1].
- In the body, peptides act as hormones, growth factors, neurotransmitters, and antimicrobial defenders, often by binding to receptors on the surface of cells [2][3].
- More than 80 peptide medicines have reached the market since insulin was introduced about a century ago [4].
- Natural peptides tend to be fragile: enzymes break them down quickly, and most cannot easily cross cell membranes [2].
- Because small chemical differences matter, peptide identity, purity, and quantity are checked with laboratory tests such as HPLC and mass spectrometry.
What Are Peptides? A Simple Definition
The international naming rules for biochemistry, published jointly by IUPAC and IUBMB (the international unions for chemistry and for biochemistry), define a peptide as any compound produced when the carboxyl group (–COOH) of one amino acid forms an amide bond with the amino group (–NH₂) of another. These amide bonds are called peptide bonds [1].
Think of amino acids as beads and peptide bonds as the links between them. String two beads together and you have a dipeptide. Three gives a tripeptide. Longer strings get more general names:
- Oligopeptides: chains of fewer than about 10–20 amino acids [1].
- Polypeptides: longer chains [1].
- Proteins: polypeptides with a specific sequence of more than about 50 amino acids are usually called proteins. The same IUPAC–IUB document notes that "authors differ greatly" on where that line falls [1].
When amino acids link up, a molecule of water is released at each new bond. What remains of each amino acid inside the chain is called an amino acid residue [1]. You will see the word "residue" often in lab reports and research papers. It simply means one amino acid unit within the chain.
If you want to go deeper on the building blocks themselves, see our guide to amino acids, the building blocks of peptides.
How Big Is a Peptide?
Peptides are small compared with most proteins. A widely cited review of therapeutic peptides describes them as usually having molecular weights between about 500 and 5,000 daltons [2]. (A dalton is a unit of mass roughly equal to the mass of one hydrogen atom.) By comparison, antibodies, a type of protein, are far larger.
Size matters because it shapes how a molecule behaves. Short chains often lack the stable folded shapes that larger proteins have, and this affects how stable they are and how they interact with the body [2]. We cover this in more detail in Peptides vs. Proteins: What's the Difference?.
Where Do Peptides Come From?
Made naturally by living things
Cells build peptides and proteins from genetic instructions. Many active peptides are cut out of larger precursor proteins. For example, glucagon-like peptide-1 (GLP-1), a 30-amino-acid hormone, is produced by specialized cells in the intestinal lining by processing a larger precursor protein called proglucagon [3].
Made in the laboratory
Chemists can also build peptides one amino acid at a time. The key breakthrough was solid-phase peptide synthesis (SPPS), first described by Bruce Merrifield in 1963 [5]. In SPPS, the growing chain is anchored to a solid resin bead while amino acids are added step by step. It remains central to modern peptide production [2]. Making peptides of fewer than about 50 residues by SPPS is now relatively routine, while very long peptides are still challenging to make at large scale [2].
Some peptides are made with recombinant DNA technology instead, using engineered microorganisms to produce them [2].
What Do Peptides Do?
Peptides do a remarkable range of jobs. According to a 2022 review in Signal Transduction and Targeted Therapy, therapeutic peptides commonly act as hormones, growth factors, neurotransmitters, ion channel ligands (molecules that bind to channels in cell membranes), or anti-infective agents. They typically bind to receptors on the cell surface and trigger effects inside the cell with high affinity and specificity [2].
A few well-known examples:
| Peptide | Approximate length | Natural role (simplified) |
|---|---|---|
| Insulin | 51 amino acids [2] | Hormone involved in regulating blood sugar |
| Gonadotropin-releasing hormone (GnRH) | 10 amino acids [2] | Brain hormone that signals the pituitary gland about reproductive hormones |
| GLP-1 | 30 amino acids [3] | Gut hormone released after meals. It stimulates insulin secretion and inhibits glucagon secretion |
| Antimicrobial peptides | Varies | Part of the natural defenses of animals and plants against bacteria, fungi, viruses, and protozoa [6] |
Antimicrobial peptides are a good reminder that peptides are not a human invention. Both animals and plants use broad-spectrum antimicrobial peptides to fend off microbes [6].
For a closer look at receptors, signaling, and why peptides act so precisely, read How Peptides Work in the Body.
Peptides in Medicine and Research
The history of peptide medicines began with insulin. Since insulin was introduced almost a century ago, more than 80 peptide drugs have reached the market for conditions including diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain [4]. The same 2022 review counted more than 170 peptides in active clinical development at the time of writing, with many more in earlier-stage research [2]. Which of these products are authorized, and for what uses, differs from country to country.
Peptides attract interest because of their precision. But natural peptides also have two well-known weaknesses [2]:
- Poor stability in the body. Enzymes can easily break peptide bonds, so many natural peptides have a short half-life and are cleared quickly.
- Poor membrane permeability. Most peptides cannot easily cross cell membranes, which limits them mainly to targets on the outside of cells.
Much of peptide drug design is about working around these limits, for example by swapping in modified amino acids or attaching groups that slow down clearance [2]. Our article on peptide half-life explains how this works.
Keep in mind that "being studied" is not the same as "shown to work in people". Many peptide findings come from cell or animal studies that may not translate to humans. Our guide on how to judge peptide research explains how to weigh different kinds of evidence.
Why Peptide Quality and Testing Matter
Because peptides are defined by their exact sequence of amino acids, even a small error, such as one missing or swapped amino acid, produces a different molecule. Manufacturing can also leave behind related impurities, water, and salts. That is why peptide materials are characterized with several complementary laboratory methods:
- Identity testing confirms that the molecule is the right one, often using mass spectrometry.
- Purity testing estimates how much of the material is the target peptide versus related impurities, typically using HPLC.
- Quantity (content) testing measures how much peptide is actually present.
The results are usually summarized in a certificate of analysis (COA). To see how these three questions differ, read Identity vs. Purity vs. Quantity Testing.
Regulatory Status
"Peptide" is a scientific term, not a legal category that means the same thing everywhere. How a particular peptide is regulated depends on the specific compound, its intended use, and the jurisdiction. For example, in the United States, federal regulations treat amino acid chains of 40 or fewer amino acids differently from larger "proteins" for regulatory purposes [7]. Other countries use their own frameworks.
Regulatory status varies by jurisdiction and may change over time. Consult the relevant regulatory authority for current information.
Frequently Asked Questions
What is the difference between a peptide and an amino acid?
An amino acid is a single building block. A peptide is two or more amino acids chemically linked by peptide bonds [1].
Are peptides the same as proteins?
They are made of the same building blocks and bonds. Proteins are generally longer chains, often folded into complex three-dimensional shapes. There is no universal cut-off: IUPAC–IUB guidance mentions about 50 residues but notes that authors differ [1], and some regulators use their own definitions [7].
Are peptides natural or synthetic?
Both. The body makes many peptides naturally, such as insulin and GLP-1 [2][3]. Peptides can also be made in laboratories by chemical synthesis or recombinant technology [2][5].
What does a peptide bond do?
A peptide bond is the amide link that joins the carboxyl group of one amino acid to the amino group of the next, forming the backbone of the chain [1].
Why do peptides break down so quickly in the body?
Natural peptides are easily cut by enzymes called proteases and are often cleared quickly, which gives many of them a short half-life [2].
Are peptides legal?
There is no single answer. Legal and regulatory status depends on the specific compound, its intended use, and the country or region. Regulatory status varies by jurisdiction and may change over time. Consult the relevant regulatory authority for current information.
References
- IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and Symbolism for Amino Acids and Peptides (Recommendations 1983), sections 3AA-11 and 3AA-12. Pure Appl Chem. 1984;56:595–624. https://doi.org/10.1351/pac198456050595 ↗ (web version: https://iupac.qmul.ac.uk/AminoAcid/A1113.html ↗)
- Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48. https://doi.org/10.1038/s41392-022-00904-4 ↗
- Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409–1439. https://doi.org/10.1152/physrev.00034.2006 ↗
- Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309–325. https://doi.org/10.1038/s41573-020-00135-8 ↗
- Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc. 1963;85(14):2149–2154. https://doi.org/10.1021/ja00897a025 ↗
- Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389–395. https://doi.org/10.1038/415389a ↗
- U.S. Code of Federal Regulations, 21 CFR 600.3(h)(6), Definitions (definition of "protein"). https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-600/subpart-A/section-600.3 ↗
Educational disclaimer: This article is for general educational purposes only. It is not medical, legal, or regulatory advice, and it does not recommend or describe the use of any product. For health questions, consult a qualified healthcare professional. For regulatory questions, consult the relevant regulatory authority in your jurisdiction.